108 related articles for article (PubMed ID: 3445125)
1. A randomized trial of postoperative radiotherapy versus observation in stage II and III renal adenocarcinoma. A study by the Copenhagen Renal Cancer Study Group.
Kjaer M; Iversen P; Hvidt V; Bruun E; Skaarup P; Bech Hansen J; Frederiksen PL
Scand J Urol Nephrol; 1987; 21(4):285-9. PubMed ID: 3445125
[TBL] [Abstract][Full Text] [Related]
2. Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer Study Group.
Kjaer M; Frederiksen PL; Engelholm SA
Int J Radiat Oncol Biol Phys; 1987 May; 13(5):665-72. PubMed ID: 3553111
[TBL] [Abstract][Full Text] [Related]
3. The value of postoperative radiotherapy in advanced renal cell cancer.
Makarewicz R; Zarzycka M; Kulińska G; Windorbska W
Neoplasma; 1998; 45(6):380-3. PubMed ID: 10210113
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinoma.
Hallemeier CL; Choo R; Davis BJ; Pisansky TM; Gunderson LL; Leibovich BC; Haddock MG
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1938-43. PubMed ID: 21514065
[TBL] [Abstract][Full Text] [Related]
5. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
6. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
7. [A retrospective study of the results of postoperative radiotherapy of hypernephroma].
Eilenberger M; Kodym R; Seyss R
Radiobiol Radiother (Berl); 1990; 31(6):491-6. PubMed ID: 2101453
[TBL] [Abstract][Full Text] [Related]
8. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients].
Chen XF; Zhou FJ; Han H; Qin ZK; Liu ZW; Yu SL; Li YH; Wang H; Hou GL
Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946
[TBL] [Abstract][Full Text] [Related]
9. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
10. [Intraoperative electron irradiation (IORT) of urologic tumors. Initial results of a pilot study of local recurrences of renal cell cancers].
Beer M; Eble MJ; Wannenmacher M; Staehler G
Urologe A; 1994 Mar; 33(2):110-5. PubMed ID: 8178404
[TBL] [Abstract][Full Text] [Related]
11. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Jonasch E; Merchant MM; Spiess PE; Wood CG
Urology; 2007 May; 69(5):835-8. PubMed ID: 17482917
[TBL] [Abstract][Full Text] [Related]
13. Postoperative radiotherapy of renal adenocarcinoma.
Mäntylä M; Nordman E; Minkkinen J
Ann Clin Res; 1977 Aug; 9(4):252-6. PubMed ID: 616210
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy.
Zubac DP; Bostad L; Gestblom C; Kihl B; Seidal T; Wentzel-Larsen T; Bakke AM
Scand J Urol Nephrol; 2007; 41(3):191-7. PubMed ID: 17469026
[TBL] [Abstract][Full Text] [Related]
15. [Local recurrence of renal cell carcinoma after nephrectomy].
Pereverzev AS; Shchukin DV; Iliukhin IuA
Urologiia; 2003; (6):14-8. PubMed ID: 14708237
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma in children. Prognostic factors.
Al-Shabanah MO; Jenkin DR; Khafaga YO; Al-Zahrani AM; Danjoux C; Greenberg M
Saudi Med J; 2004 Nov; 25(11):1583-6. PubMed ID: 15573183
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy of kidney cancer].
Schulz U
Urologe A; 1986 Jan; 25(1):4-6. PubMed ID: 3962042
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant autologous tumour cell-lysate vaccine versus no adjuvant treatment in patients with M0 renal cell carcinoma after radical nephrectomy: 3-year interim analysis of a German multicentre phase-III trial.
Doehn Ch; Richter A; Lehmacher W; Jocham D
Folia Biol (Praha); 2003; 49(2):69-73. PubMed ID: 12779015
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.
Klatte T; Chung J; Leppert JT; Lam JS; Pantuck AJ; Figlin RA; Belldegrun AS
BJU Int; 2007 Apr; 99(4):821-4. PubMed ID: 17244281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
